Published by Reuters   (Reuters) -Novavax Inc said on Monday its combined flu and COVID-19 vaccine produced functional antibodies against influenza and the coronavirus in a preclinical study. The company said the NanoFlu/NVX-CoV2373 vaccine elicited robust responses to both influenza A and B and protected against the SARS-CoV-2 virus. (https://refini.tv/3bg25TM) “Seasonal influenza and COVID-19 … Continue reading Combined Flu/COVID Vaccine Shows Promise in Novavax Study, Likely Needed to Fight Variants